Imagine losing the strength to move, day by day, as your skeletal muscles slowly deteriorate. This is a reality for the 1 in 8,000 people around the world who have facioscapulohumeral muscular dystrophy, or FSHD. Here’s what you need to know about this debilitating disease: 🧬 FSHD is one of the most common forms of muscular dystrophy. 🌎 It affects individuals regardless of age, gender, ethnicity, race, or geographic location. ❌ There is currently no cure for FSHD. But, the $10M FSHD Bonus Prize, launched alongside the $101M #XPRIZEHealthspan global competition, aims to change that. It’s not too late to register for the FSHD Bonus Prize to find novel solutions and therapeutics that can demonstrate substantial improvement in muscle function for those with FSHD in less than a year. Join us in bringing hope to those living with this disease. Register a team by Dec. 20 and complete your Qualifying Submission by Dec. 31. https://lnkd.in/gZ_KaN78 The $10M FSHD Bonus Prize is made possible thanks to the generosity of SOLVE FSHD.
Interesting approach to tackle FSHD. Sorry that the video depicted individuals with difficulties with motor function but not with FSHD--would have been a good educational opportunity--and indiviuals with FSHD are so beautiful!
Learn more here. https://www.businesswire.com/news/home/20241205173475/en/SOLVE-FSHD-Challenges-Innovators-with-USD10-Million-Bonus-Prize-to-Accelerate-FSHD-Breakthroughs-in-XPRIZE-Healthspan-Competition